LB Pharmaceuticals Inc Common Stock
LBRX • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 62%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.30B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.01Healthy liquidity · 41.44Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 12, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:09 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$1.30B
52W Range13.36 - 49.14
Beta0.42
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.01
Current Ratio41.44
Quick Ratio41.44
Target$47.86
Price$0.00
Change0.00%
Market Cap$1.30B
52W Range13.36 - 49.14
Beta0.42
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.01
Current Ratio41.44
Quick Ratio41.44
Target$47.86
Target Median$45.00
Target Range36.00 - 78.00
Volume353.91K
Avg Volume289.71K
EPS Surprise0.08
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
88/100
Why this score▼
Manageable debt level · 0.01Healthy liquidity · 41.44Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-13
Low
$36.00
Mean
$47.86
Median
$45.00
High
$78.00
🧾
No insider activity
No recent insider transactions available.